Plantar Fascitis

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

L
LabcorpNC - Burlington
1 program
Percutaneous tenotomy + PRPN/A1 trial
Active Trials
NCT05622279Completed19Est. Aug 2025

Trial Timeline

Clinical trial activity over time

2023
2024
2025
2026
LabcorpPercutaneous tenotomy + PRP

Clinical Trials (1)

Total enrollment: 19 patients across 1 trials

NCT05622279LabcorpPercutaneous tenotomy + PRP

Percutaneous Needle Tenotomy Associated With Platelet-rich Plasma Injection Platelet-rich Plasma in the Treatment of Refractory Plantar Fasciitis: a Pilot Study of the Effect on Pain and Tolerance

Start: Jan 2023Est. completion: Aug 202519 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space